A case of insulinoma with hypoglycemia that was better managed with lanreotide than octreotide

Long‐acting somatostatin analogs, including lanreotide slow release (LAN‐SR) and octreotide long‐acting release (OCT‐LAR), can improve hypoglycemia in insulinoma. LAN‐SR may be more beneficial in some patients with insulinoma than OCT‐LAR.

保存先:
書誌詳細
出版年:Clin Case Rep
主要な著者: Yamaoka, Keiko, Nagashima, Shuichi, Okada, Nobukazu, Sawayama, Nagisa, Saito, Shinsuke, Takahashi, Manabu, Okada, Kenta, Endo, Kazuhiro, Koizumi, Masaru, Sasanuma, Hideki, Ebihara, Ken, Kasajima, Atsuko, Fukushima, Noriyoshi, Sata, Naohiro, Ishibashi, Shun
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley and Sons Inc. 2021
主題:
Case Reports
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8133073/
https://ncbi.nlm.nih.gov/pubmed/34026158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.4118
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料